33. Rossi D. et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors // Br. J. Haematol. 2009. Vol. 146, N 1. P. 64–75.
34. Kern W. et al. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL // Br. J. Haematol. 2012. Vol. 157, N 1. P. 86–96.
35. Shanafelt T.D. et al. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome // Blood. 2009. Vol. 113, N 18. P. 4188–4196.
36. Maitre E., Troussard X. Monoclonal B-cell lymphocytosis // Best Pract. Res. Clin. Haematol. 2019. Vol. 32, N 3. P. 229–238.
37. Rossi D. et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors // Br. J. Haematol. 2009. Vol. 146, N 1. P. 64–75.
38. Lanasa M.C. et al. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL // Leukemia. 2011. Vol. 25, N 9. P. 1459–1466.
39. Gibson S.E. et al. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis // Haematologica. 2011. Vol. 96, N 8. P. 1144–1152.
40. Ghia P. Another piece of the puzzle: is there a «nodal» monoclonal B-cell lymphocytosis? // Haematologica. 2011. Vol. 96, N 8. P. 1089–1091.
41. Berkowska M.A. et al. Persistent polyclonal B-cell lymphocytosis: extensively proliferated CD27+Ig- M+IgD+ memory B cells with a distinctive immunophenotype // Leukemia. 2014. Vol. 28, N 7. P. 1560–1564.
42. Moreira J. et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls // Leukemia. 2013. Vol. 27, N 1. P. 136–141.
43. Kay N.E. Abnormal T-cell subpopulation function in CLL: excessive suppressor (Tγ) and deficient helper (Tµ) activity with respect to B-cell proliferation // Blood. 1981. Vol. 57, N 3. P. 418–420.
44. te Raa G.D. et al. Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis // Leuk. Lymphoma. 2012. Vol. 53, N 11. P. 2321–2325.
45. Zeya H.I. et al. Monocyte and granulocyte defect in chronic lymphocytic leukemia // Am. J. Pathol. 1979. Vol. 95, N 1. P. 43–54.
46. Parikh S.A. et al. Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis // Haematologica. 2018. Vol. 103, N 6. P. e237–e240.
47. Sánchez-Ramón S., Dhalla F., Chapel H. Challenges in the role of gammaglobulin replacement therapy and vaccination strategies for hematological malignancy // Front. Immunol. 2016. Vol. 7. P. 317.
48. Solomon. B.M. et al. Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis // Leukemia. 2016. Vol. 30, N 2. P. 331–336.
49. Mittal S. et al. A high rate of CLL phenotype lymphocytes in autoimmune hemolytic anemia and immune thrombocytopenic purpura // Haematologica. 2008. Vol. 93, N 1. P. 151–152.
50. Strati P. et al. Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience // Haematologica. 2015. Vol. 100, N 9. P. 1180–1188.
51. Htet Z.M. et al. Multiple faces of chronic lymphocytic leukaemia: a patient with renal, cardiac, and skeletal complications // Case Rep. Nephrol. 2019. Vol. 2019. Article ID 5390235.
52. Ratterman M. et al. Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012 // Leuk. Res. 2014. Vol. 38, N 3. P. 299–303.
53. Phillips J.K. et al. Renal failure caused by leukaemic infiltration in chronic lymphocytic leukaemia // J. Clin. Pathol. 1993. Vol. 46, N 12. P. 1131–1133.
54. Wanchoo R. et al. Renal involvement in chronic lymphocytic leukemia // Clin. Kidney J. 2018. Vol. 11, N 5. P. 670–680.
55. Wynsberghe M.V. et al. Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance? // J. Nephrol. 2018. Vol. 31, N 2. P. 317–320.
56. Nieto W.G. et al. Commentary: comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection // Cytometry B Clin. Cytom. 2010. Vol. 78, suppl. 1. P. S4–S9.
57. Nieto W.G. et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach // Blood. 2009. Vol. 114, N 1. P. 33–37.
58. Vardi A. et al. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL // Blood. 2013. Vol. 121, N 22. P. 4521–4528.
59. Fazi C. et al. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL // Blood. 2011. Vol. 118, N 25. P. 6618–6625.
60. Agathangelidis A. et al. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations // Haematologica. 2018. Vol. 103, N 5. P. 865–873.
61. Agathangelidis A. et al. High-throughput analysis of the T cell receptor gene repertoire in low-count monoclonal B cell lymphocytosis reveals a distinct profile from chronic lymphocytic leukemia // Haematologica. 2020. Vol. 105, N 10. Article ID 221275.
62. Criado I. et al. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome // Haematologica. 2018. Vol. 103, N 7. P. 1198–1208.
63. Shim Y.K. et al. Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding // Blood. 2014. Vol. 123, N 9. P. 1319–1326.